OasisLMS

Pharmacotherapy of Substance Use Disorders in Adolescents

Justine Welsh, MD

Addiction Psychopharmacology of those with Co-Morbid Medical Conditions

Kevin Sevarino, MD, PhD

Pharmacotherapy of Depressive and Anxiety Disorders with Co-Occurring Substance Use Disorders

Edward Nunes, MD

Pharmacotherapy: Perinatal Substance Use Disorders

Constance Guille, MD

Pharmacotherapy of Insomnia with Co-Occurring Substance Use Disorders

Christina Brezing, MD

Pharmacotherapy of Post-Traumatic Stress Disorder with Co-Occurring Substance Use Disorders

Ismene Petrakis, MD

Pharmacotherapy of Bipolar Disorder and Schizophrenia with Co-Occurring Substance Use Disorders

John Mariani, MD

Pharmacotherapy of ADHD with Co-Occurring Substance Use Disorders

Frances Levin, MD

Christina A. Brezing, MD

Course Co-Director / Live & On-Demand Faculty

Assistant Professor of Psychiatry, Division on Substance Use Disorders, Columbia University Irving Medical Center; Research Scientist, New York State Psychiatric Institute

Constance Guille, MD

Live & On-Demand Faculty

Professor, Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, and Director, Women’s Reproductive Behavioral Health Division, Medical University of South Carolina (MUSC)

Frances Levin, MD

Live & On-Demand Faculty

Kennedy-Leavy Professor of Psychiatry, Columbia University; Chief, Division on Substance Use Disorders, NYSPI/Columbia University

John J. Mariani, MD

Live & On-Demand Faculty

Professor of Clinical Psychiatry, Columbia University Vagelos College of Physicians and Surgeons; Director, Substance Treatment and Research Service (STARS), Division on Substance Use Disorders, NYSPI/Columbia University Irving Medical Center

Edward V. Nunes, MD

Live & On-Demand Faculty

Professor of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute (NYSPI); Principal Investigator, Greater New York Node of the NIDA Clinical Trials Network

Ismene L. Petrakis, MD

Live & On-Demand Faculty

Professor of Psychiatry, Yale University School of Medicine; Chief of Psychiatry and Mental Health Services, VA Connecticut Healthcare System

Kevin A. Sevarino, MD, PhD

Course Co-Director / Live & On-Demand Faculty

Associate Clinical Professor of Psychiatry, Yale University School of Medicine; Medical Director, American Academy of Addiction Psychiatry (AAAP)

Justine W. Welsh, MD

Live & On-Demand Faculty

Associate Professor, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine; Vice Chair for Child, Adolescent, and Young Adult Programs; Director, Emory Healthcare Addiction Services

Accreditation Statement

Credit Designation Statements

Physicians
American Academy of Addiction Psychiatry designates this other activity (one portion of this course is an independent online activity and another portion of this course is a live educational exchange with a clinical expert responding to learner questions) for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Health Professionals and Other Learners
Participants will receive a certificate stating this program is designated for 14.75 AMA PRA Category 1 Credits™.  This credit is accepted by the AANP and the AAPA. 

Cancellation Policy

A 100% refund will be honored for cancellations requested in writing within 48 hours of purchase. No refunds will be honored after 48 hours of purchase. All refund requests must be submitted in writing to cmecpd@aaap.org.

ADA Accommodation Statement

AAAP encourage persons with disabilities to participate in our programs and activities. If you anticipate needing any type of accommodation or have questions about this activity, please email cmecpd@aaap.org.

Privacy and Confidentiality Policy

AAAP values your privacy and the confidentiality of the information you choose to share with us. Personal information collected from evaluations will not be shared with third parties. 

AAAP Disclaimer

The views, opinions, and content expressed herein do not necessarily reflect the views or policies of AAAP, CSAT, SAMHSA, or HHS. No official support of or endorsement by AAAP, CSAT, SAMHSA, or HHS for these opinions or for particular instruments, software, or resources is intended or should be inferred.

Code of Conduct: 
It is the policy of the American Academy of Addiction Psychiatry (AAAP) that all participants, including attendees, vendors, and staff, conduct themselves in a professional manner that is welcoming to all participants. Participants should treat each other with mutual respect, well-being, and collegiality. All individuals agree to conduct themselves in a manner appropriate for healthcare professionals.
Participants will avoid any inappropriate actions or statements based on individual characteristics such as age, race, ethnicity, sexual orientation, gender identity, gender expression, marital status, nationality, political affiliation, ability status, educational background, or any other characteristic protected by law. Disruptive or harassing behavior of any kind will not be tolerated.

If an individual believes that this policy has been violated or breached, he/she shall notify AAAP staff to assist with the situation. AAAP reserves the right to remove meeting access for any individual violating this policy and will not provide a refund. By registering for this meeting, you agree to abide by the Code of Conduct Policy as described above.

Virtual Image Capture and Voice Recording Notice: 
By registering for this event, you agree to be recorded visually and/or audibly during any and all virtual engagement activities, and that the American Academy of Addiction Psychiatry (AAAP) is allowed to use any and all virtual image captures and/or recordings in which you appear for future educational materials and AAAP marketing efforts. It is with the understanding that you acknowledge that your image and/or voice may be captured without compensation during the event and you waive the right to inspect or approve any future documents in which they appear. 

Disclosure to Learners

In accordance with the disclosure policy of the American Academy of Addiction Psychiatry, as well as standards set forth by JAC policies and guidelines and the ACCME, the JAC expects accredited providers to present learners with unbiased, independent, and objective information in all activities. Accredited providers must be in compliance with the Standards for Integrity and Independence in Accredited Continuing Education. Therefore, Presenter(s), Planner(s), Reviewer(s), and all others involved in the planning or content development of this activity were required to disclose all financial relationships within the past 24 months.

For this activity, the following relevant financial relationships were disclosed:

All disclosures have been reviewed, and all relevant financial relationships have been mitigated. 

All other individuals involved in the planning and presentation of this activity have no relevant financial relationships with ineligible companies to disclose.

All speakers have been advised that any recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in the presentation must conform to the generally accepted standards of experimental design, data collection, and analysis. Faculty have also been advised that they must not actively promote or sell products or services that serve their professional or financial interests during accredited education.

Copyright © 2026 American Academy of Addiction Psychiatry